Fintel reports that on July 10, 2025, Piper Sandler upgraded their outlook for Oracle (NYSE:ORCL) from Neutral to Overweight. Analyst Price Forecast Suggests 8.42% Downside As of June 20, 2025 ...

Fintel reports that on June 30, 2025, Stifel upgraded their outlook for Oracle (NYSE:ORCL) from Hold to Buy. Analyst Price Forecast Suggests 2.72% Upside As of June 20, 2025, the average one-year ...

Oracle Corporation (NYSE: ORCL) is one of the 10 software stocks analysts are upgrading. On June 12, Citi raised the price target on the company’s stock to $196 from $186, while keeping a ...

Pace Pharmacy was one of the last pharmacies that would fill prescriptions of Dr. Elaine Sharp, accused of running a longtime pill mill operation.

A significant trading signal occurred for Oracle stock, as it demonstrated a power inflow at $206.95, after which ORCL rose up to 4.7%.

Investor Takeaway The ORCL stock has become a textbook example of how recency bias in the equity market could create significant opportunities that are hiding in plain sight.

ORCL shares reached record levels Thursday after Oracle's revenue growth beat Wall Street expectations—and showed no signs of slowing.

Oracle Corporation (NYSE: ORCL) is set to spend about $40 billion on Nvidia’s top-tier chips to support OpenAI’s upcoming data center in the US, according to Financial Times.

Rite Aid has sold the pharmacy services of most of its stores across the United States to several rivals.

Pace Pharmacy was raided and owners Stephen and Monique Burklow were arrested for allegedly 'pushing 100+ lbs of opioids into Florida communities.' ...